Form D — Iantrek, Inc.
0001829982-25-000003 · filed Aug 21, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $41,986,763
- Reported amount sold
- $34,748,596
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Iantrek, Inc.
- CIK
- 1829982
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 151 EAST POST ROAD
WHITE PLAINS, New York 10601 - Phone
- 9147086540
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michael Haydin · Executive OfficerWhite Plains, New York Find on LinkedIn ↗
-
Marc-Andre Marcotte · DirectorMontreal, Quebec, Canada Find on LinkedIn ↗
-
Farrell Tyson · DirectorCape Coral, Florida Find on LinkedIn ↗
-
Tsontcho Ianchulev · Executive OfficerWhite Plains, New York Find on LinkedIn ↗
-
James Mazzo · DirectorLaguna Beach, California Find on LinkedIn ↗
-
Jeffry K. Weinhuff · DirectorAliso Viejo, California Find on LinkedIn ↗
-
Robert Weinreb · DirectorRancho Santa Fe, California Find on LinkedIn ↗
-
Adam Szaronos · Executive OfficerKeller, Texas Find on LinkedIn ↗
-
Todd Sone · DirectorBeit Gamla B, Ra'anana, Israel Find on LinkedIn ↗
-
Casey Tansey · DirectorMenlo Park, California Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗